206 related articles for article (PubMed ID: 18223474)
1. The pharmacokinetic profile of voriconazole during continuous high-volume venovenous hemofiltration in a critically ill patient.
Quintard H; Papy E; Massias L; Lasocki S; Arnaud P; Desmonts JM; Montravers P
Ther Drug Monit; 2008 Feb; 30(1):117-9. PubMed ID: 18223474
[TBL] [Abstract][Full Text] [Related]
2. Disposition of voriconazole during continuous veno-venous haemodiafiltration (CVVHDF) in a single patient.
Robatel C; Rusca M; Padoin C; Marchetti O; Liaudet L; Buclin T
J Antimicrob Chemother; 2004 Jul; 54(1):269-70. PubMed ID: 15175271
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic evaluation of voriconazole treatment in critically ill patients undergoing continuous venovenous hemofiltration.
Radej J; Krouzecky A; Stehlik P; Sykora R; Chvojka J; Karvunidis T; Novak I; Matejovic M
Ther Drug Monit; 2011 Aug; 33(4):393-7. PubMed ID: 21654349
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of voriconazole during continuous venovenous haemodiafiltration.
Fuhrmann V; Schenk P; Jaeger W; Miksits M; Kneidinger N; Warszawska J; Holzinger U; Kitzberger R; Thalhammer F
J Antimicrob Chemother; 2007 Nov; 60(5):1085-90. PubMed ID: 17855725
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of voriconazole during continuous venovenous hemofiltration.
Spriet I; Wauters J; Willems L
Ther Drug Monit; 2011 Jun; 33(3):372; author reply 372. PubMed ID: 21566509
[No Abstract] [Full Text] [Related]
6. Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration.
Tegeder I; Neumann F; Bremer F; Brune K; Lötsch J; Geisslinger G
Clin Pharmacol Ther; 1999 Jan; 65(1):50-7. PubMed ID: 9951430
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of voriconazole after oral administration of single and multiple doses in Hispaniolan Amazon parrots (Amazona ventralis).
Sanchez-Migallon Guzman D; Flammer K; Papich MG; Grooters AM; Shaw S; Applegate J; Tully TN
Am J Vet Res; 2010 Apr; 71(4):460-7. PubMed ID: 20367055
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic profile of voriconazole in a critically ill patient on therapeutic plasma exchange.
Spriet I; Brüggemann RJ; Annaert P; Meersseman P; Van Wijngaerden E; Lagrou K; Willems L
Ther Drug Monit; 2013 Feb; 35(1):141-3. PubMed ID: 23296095
[TBL] [Abstract][Full Text] [Related]
9. Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients.
Isla A; Gascón AR; Maynar J; Arzuaga A; Toral D; Pedraz JL
Clin Ther; 2005 May; 27(5):599-608. PubMed ID: 15978309
[TBL] [Abstract][Full Text] [Related]
10. Variability of voriconazole plasma levels measured by new high-performance liquid chromatography and bioassay methods.
Pascual A; Nieth V; Calandra T; Bille J; Bolay S; Decosterd LA; Buclin T; Majcherczyk PA; Sanglard D; Marchetti O
Antimicrob Agents Chemother; 2007 Jan; 51(1):137-43. PubMed ID: 17088483
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of voriconazole after single dose intravenous and oral administration to alpacas.
Chan HM; Duran SH; Walz PH; Ravis WR
J Vet Pharmacol Ther; 2009 Jun; 32(3):235-40. PubMed ID: 19646087
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of voriconazole after oral administration of single and multiple doses in African grey parrots (Psittacus erithacus timneh).
Flammer K; Nettifee Osborne JA; Webb DJ; Foster LE; Dillard SL; Davis JL
Am J Vet Res; 2008 Jan; 69(1):114-21. PubMed ID: 18167096
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of voriconazole after oral and intravenous administration to horses.
Davis JL; Salmon JH; Papich MG
Am J Vet Res; 2006 Jun; 67(6):1070-5. PubMed ID: 16740104
[TBL] [Abstract][Full Text] [Related]
14. Teicoplanin pharmacokinetics in critically ill patients on continuous veno-venous hemofiltration.
Bellmann R; Falkensammer G; Seger C; Weiler S; Kountchev J; Joannidis M
Int J Clin Pharmacol Ther; 2010 Apr; 48(4):243-9. PubMed ID: 20353745
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of oral voriconazole in patients with cystic fibrosis.
Clifton IJ; Whitaker P; Metcalfe R; Phillip M; Shaw N; Conway SP; Peckham DG
J Antimicrob Chemother; 2011 Oct; 66(10):2438-40. PubMed ID: 21791443
[No Abstract] [Full Text] [Related]
16. Monitoring plasma voriconazole levels following intravenous administration in critically ill patients: an observational study.
Myrianthefs P; Markantonis SL; Evaggelopoulou P; Despotelis S; Evodia E; Panidis D; Baltopoulos G
Int J Antimicrob Agents; 2010 May; 35(5):468-72. PubMed ID: 20188523
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of voriconazole following intravenous and oral administration and body fluid concentrations of voriconazole following repeated oral administration in horses.
Colitz CM; Latimer FG; Cheng H; Chan KK; Reed SM; Pennick GJ
Am J Vet Res; 2007 Oct; 68(10):1115-21. PubMed ID: 17916020
[TBL] [Abstract][Full Text] [Related]
18. Multiple-dose pharmacokinetics of daptomycin during continuous venovenous haemodiafiltration.
Wenisch JM; Meyer B; Fuhrmann V; Saria K; Zuba C; Dittrich P; Thalhammer F
J Antimicrob Chemother; 2012 Apr; 67(4):977-83. PubMed ID: 22210754
[TBL] [Abstract][Full Text] [Related]
19. Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes.
Pascual A; Calandra T; Bolay S; Buclin T; Bille J; Marchetti O
Clin Infect Dis; 2008 Jan; 46(2):201-11. PubMed ID: 18171251
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of levofloxacin during continuous venovenous hemodiafiltration and continuous venovenous hemofiltration in critically ill patients.
Guenter SG; Iven H; Boos C; Bruch HP; Muhl E
Pharmacotherapy; 2002 Feb; 22(2):175-83. PubMed ID: 11837556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]